ReviewKorean circulation journal2019
Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications.
Review in Korean circulation journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Left ventricular assist devices and right heart dysfunction: a review of impact mechanisms, evaluation methods, and prevention and management.Journal of cardiothoracic surgery · 2026Review
- Article
- Identifying key CT features and clinical variables for predicting operative management of left ventricular assist device (LVAD) driveline infections.Emergency radiology · 2025Article
- Left ventricular assist device exchanges: A safe and effective strategy in the era of limited organ availability.The International journal of artificial organs · 2025Article
- Prediction of Right Heart Failure in LVAD Candidates: Current Approaches and Future Directions.Journal of cardiovascular development and disease · 2025Review
- A minimum dataset for destination therapy with left ventricular assist device: the evidence that matters to decision makers.International journal of technology assessment in health care · 2025Article
- Biosensors with left ventricular assist devices.Heart failure reviews · 2024Review
- Heart Transplantation and Left Ventricular Assist Devices: Long-Term Prognosis and Effects on Mental Health.Cureus · 2024Review
- Emergent decommissioning of HeartMate 3 for life-threatening hemorrhage.Journal of vascular surgery cases and innovative techniques · 2024Article
- Trend of left ventricular assist device related complications: Insight from the National Inpatient Sample Database.American heart journal plus : cardiology research and practice · 2023Article
- Antithrombotic therapy for durable left ventricular assist devices - current strategies and future directions.Indian journal of thoracic and cardiovascular surgery · 2022Review
- Threatened Ventricular Assist Devices: Meta-analysis of Negative Pressure Therapy and Flap Reconstruction Outcomes.Plastic and reconstructive surgery. Global open · 2022Article
- Approaches to ventricular assist device exchange: Resternotomy versus limited incisions.JTCVS techniques · 2022Article
- Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.The Korean journal of internal medicine · 2022Article
- In medicine, how do we machine learn anything real?Patterns (New York, N.Y.) · 2022Review
- Is Left Ventricular Assist Device Deactivation Ethically Acceptable? A Study on the Euthanasia Debate.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2021Article
- Economic Burden of Heart Failure in Asian Countries Based on Real-world Data.Korean circulation journal · 2021Article
- Contemporary outcomes of continuous-flow biventricular assist devices.Annals of cardiothoracic surgery · 2021Article
- Pericardial release for early LVAD malalignment a less invasive approach.Clinical case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congestive heart failure is a major cause of morbidity and mortality as well as a major health care cost in the developed world. Despite the introduction of highly effective heart failure medical therapies and simple devices such as cardiac resynchronization therapy that reduce mortality, improve cardiac function and quality of life, there remains a large number of patients who do not respond to these therapies or whose heart failure progresses despite optimal therapy. For these patients, cardiac transplantation is an option but is limited by donor availability as well as co-morbidities which may limit survival post-transplant. For these patients, left ventricular assist devices (LVADs) offer an alternative that can improve survival as well as exercise tolerance and quality of life. These devices have continued to improve as technology has improved with substantially improved durability of the devices and fewer post-implant complications. Pump thrombosis, stroke, gastrointestinal bleeding and arrhythmias post-implant have become less common with the newest devices, making destination therapy where ventricular assist device are implanted permanently in patients with advanced heart failure, a reality and an appropriate option for many patients. This may offer an opportunity for long term survival in many patients. As the first of the totally implantable devices are introduced and go to clinical trials, LVADs may be introduced that may truly be alternatives to cardiac transplantation in selected patients. Post-implant right ventricular failure remains a significant complication and better ways to identify patients at risk as well as to manage this complication must be developed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.